» Articles » PMID: 19528250

Differential Action of Bradykinin on Intrarenal Regional Perfusion in the Rat: Waning Effect in the Cortex and Major Impact in the Medulla

Overview
Journal J Physiol
Specialty Physiology
Date 2009 Jun 17
PMID 19528250
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The renal kallikrein-kinin system is involved in the control of the intrarenal circulation and arterial pressure but bradykinin (Bk) effects on perfusion of individual kidney zones have not been examined in detail. Effects of Bk infused into renal artery, renal cortex or medulla on perfusion of whole kidney (RBF, renal artery probe) and of the cortex, outer- and inner medulla (CBF, OMBF, IMBF: laser-Doppler fluxes), were examined in anaesthetized rats. Renal artery infusion of Bk, 0.3-0.6 mg kg(-1) h(-1), induced no sustained increase in RBF or CBF. OMBF and IMBF increased initially 6 or 16%, respectively; only the IMBF increase (+10%) was sustained. Pre-treatment with L-NAME, 2.4 mg kg(-1) I.V., prevented the sustained but not initial transient elevation of medullary perfusion. Intracortical Bk infusion, 0.75-1.5 mg kg(-1) h(-1), did not alter RBF or CBF but caused a sustained 33% increase in IMBF. Intramedullary Bk, 0.3 mg kg(-1) h(-1), did not alter RBF or CBF but caused sustained increases in OMBF (+10%) and IMBF (+23%). These responses were not altered by pre-treatment with 1-aminobenzotriazole, 10 mg kg(-1)i.v., a cytochrome P-450 (CYP450) inhibitor, but were prevented or significantly attenuated by L-NAME or intramedullary clotrimazole, 3.9 mg kg(-1) h(-1), an inhibitor of CYP450 epoxygenase and of calcium-dependent K(+) channels (K(Ca)). Thus, cortical vasodilatation induced by Bk is only transient so that the agent is unlikely to control perfusion of the cortex. Bk selectively increases perfusion of the medulla, especially of its inner layer, via activation of the NO system and of K(Ca) channels.

Citing Articles

Chronic Overexpression of Bradykinin in Kidney Causes Polyuria and Cardiac Hypertrophy.

Barros C, Schadock I, Sihn G, Rother F, Xu P, Popova E Front Med (Lausanne). 2018; 5:338.

PMID: 30560131 PMC: 6287039. DOI: 10.3389/fmed.2018.00338.


Evidence against a crucial role of renal medullary perfusion in blood pressure control of hypertensive rats.

Badzynska B, Baranowska I, Gawrys O, Sadowski J J Physiol. 2018; 597(1):211-223.

PMID: 30334256 PMC: 6312421. DOI: 10.1113/JP276342.


1-Aminobenzotriazole: A Mechanism-Based Cytochrome P450 Inhibitor and Probe of Cytochrome P450 Biology.

de Montellano P Med Chem (Los Angeles). 2018; 8(3).

PMID: 30221034 PMC: 6137267. DOI: 10.4172/2161-0444.1000495.


Role of Mas Receptor Antagonist A799 in Renal Blood Flow Response to Ang 1-7 after Bradykinin Administration in Ovariectomized Estradiol-Treated Rats.

Dehghani A, Saberi S, Nematbakhsh M Adv Pharmacol Sci. 2015; 2015:801053.

PMID: 26421009 PMC: 4573425. DOI: 10.1155/2015/801053.

References
1.
Tornel J, Madrid M, Garcia-Salom M, Wirth K, Fenoy F . Role of kinins in the control of renal papillary blood flow, pressure natriuresis, and arterial pressure. Circ Res. 2000; 86(5):589-95. DOI: 10.1161/01.res.86.5.589. View

2.
Katori M, Majima M . Pivotal role of renal kallikrein-kinin system in the development of hypertension and approaches to new drugs based on this relationship. Jpn J Pharmacol. 1996; 70(2):95-128. DOI: 10.1254/jjp.70.95. View

3.
Vio C, Loyola S, Velarde V . Localization of components of the kallikrein-kinin system in the kidney: relation to renal function. State of the art lecture. Hypertension. 1992; 19(2 Suppl):II10-6. DOI: 10.1161/01.hyp.19.2_suppl.ii10. View

4.
Moreau M, Garbacki N, Molinaro G, Brown N, Marceau F, Adam A . The kallikrein-kinin system: current and future pharmacological targets. J Pharmacol Sci. 2005; 99(1):6-38. DOI: 10.1254/jphs.srj05001x. View

5.
Flamenbaum W, Gagnon J, Ramwell P . Bradykinin-induced renal hemodynamic alterations: renin and prostaglandin relationships. Am J Physiol. 1979; 237(6):F433-40. DOI: 10.1152/ajprenal.1979.237.6.F433. View